Alison Bateman-House is assistant professor in the NYU Grossman School of Medicine Division of Medical Ethics. She co-chairs the Working Group on Compassionate Use and Preapproval Access, which studies ethical issues concerning access to investigational medical products, and co-chairs the Pediatric Gene Therapy Medical Ethics working group. She advises biopharmaceutical companies, patient advocacy organizations, and governmental and non-governmental entities and serves on numerous data safety monitoring boards overseeing clinical trials. Bateman-House is primary investigator for the NYU/Janssen Pharmaceutical Compassionate Use Advisory Committees. In 2021, Bateman-House received the Columbia University Mailman School of Public Health Outstanding Recent Alumni Award. She has published and spoken extensively on access to investigational medical products, equity in clinical trials, individualized therapeutics, the history and ethics of using humans as research subjects, and public health ethics.
Previously
Remarkable screening and diagnostic tools are being developed so that disease can be identified in its earliest stages, when it is most treatable, and disease subtypes can be...
This interactive session led by Ideo.org recognizes that little is more personal than the health of our minds and bodies and that deciding to seek out healthcare is to acknowl...